Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Fukuda

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
The Oncologist|July 10, 2025
Sporadic medullary thyroid carcinoma with a rare RET transmembrane domain mutation (A641R) that responds to selpercatinibNaoki Fukuda, Kazuhisa Toda, Tomohiro Chiba, et al.
International Cancer Conference Journal|January 27, 2026
Acute esophageal mucosal injury during pembrolizumab treatment after a hypopharyngeal cancer patient's free jejunal autograft reconstruction, as an immune-related adverse eventYuten Shuri, Kenji Nakano, Koichi Takeda, et al.
ACG Case Reports Journal|January 26, 2017
Successful Endoscopic Management of Non-Healing Perforated Duodenal Ulcer with Polyglycolic Acid Sheet and Fibrin GlueTsuyoshi Mishiro, Kotaro Shibagaki, Kayo Matsuda, et al.
Cancers|December 24, 2021
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue SarcomaYasuyoshi Sato, Kenji Nakano, Xiaofei Wang, et al.
Oncology|January 31, 2022
Post-Systemic Chemotherapy Prognoses of Recurrent/Metastatic Soft Tissue Sarcoma Patients with Retroperitoneal/Intra-Abdominal Origin versus Those with Extremities/Trunk OriginKenji Nakano, Naoki Fukuda, Yasuyoshi Sato, et al.
Plos One|March 1, 2023
Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective studyAkihiro Ohmoto, Kenji Nakano, Naoki Fukuda, et al.
Oncology Letters|January 8, 2025
Confirmatory diagnosis and successive chemotherapeutic treatments of metastatic skeletal <i>EWSR1::NFATC2</i> sarcoma: A case reportTetsuya Urasaki, Makiko Ono, Kyoko Yamashita, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
The Oncologist|July 10, 2025
Sporadic medullary thyroid carcinoma with a rare RET transmembrane domain mutation (A641R) that responds to selpercatinibNaoki Fukuda, Kazuhisa Toda, Tomohiro Chiba, et al.
International Cancer Conference Journal|January 27, 2026
Acute esophageal mucosal injury during pembrolizumab treatment after a hypopharyngeal cancer patient's free jejunal autograft reconstruction, as an immune-related adverse eventYuten Shuri, Kenji Nakano, Koichi Takeda, et al.
ACG Case Reports Journal|January 26, 2017
Successful Endoscopic Management of Non-Healing Perforated Duodenal Ulcer with Polyglycolic Acid Sheet and Fibrin GlueTsuyoshi Mishiro, Kotaro Shibagaki, Kayo Matsuda, et al.
Cancers|December 24, 2021
Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue SarcomaYasuyoshi Sato, Kenji Nakano, Xiaofei Wang, et al.
Oncology|January 31, 2022
Post-Systemic Chemotherapy Prognoses of Recurrent/Metastatic Soft Tissue Sarcoma Patients with Retroperitoneal/Intra-Abdominal Origin versus Those with Extremities/Trunk OriginKenji Nakano, Naoki Fukuda, Yasuyoshi Sato, et al.
Plos One|March 1, 2023
Clinical characteristics of sarcoma cases in which long-term disease control was achieved with trabectedin treatment: A retrospective studyAkihiro Ohmoto, Kenji Nakano, Naoki Fukuda, et al.
Oncology Letters|January 8, 2025
Confirmatory diagnosis and successive chemotherapeutic treatments of metastatic skeletal <i>EWSR1::NFATC2</i> sarcoma: A case reportTetsuya Urasaki, Makiko Ono, Kyoko Yamashita, et al.
Pageof 11